Company registration number 04381321 (England and Wales)
EUROPEAN HEALTHCARE SOLUTIONS LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
PAGES FOR FILING WITH REGISTRAR
EUROPEAN HEALTHCARE SOLUTIONS LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 6
EUROPEAN HEALTHCARE SOLUTIONS LIMITED
BALANCE SHEET
AS AT
31 MARCH 2025
31 March 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
3
53,820
63,689
Investment property
4
215,863
215,863
Investments
5
100
100
269,783
279,652
Current assets
Debtors
6
1,948
8,862
Cash at bank and in hand
12,320
28,979
14,268
37,841
Creditors: amounts falling due within one year
7
(64,548)
(80,985)
Net current liabilities
(50,280)
(43,144)
Total assets less current liabilities
219,503
236,508
Creditors: amounts falling due after more than one year
8
(19,893)
(25,513)
Provisions for liabilities
(5,042)
(15,922)
Net assets
194,568
195,073
Capital and reserves
Called up share capital
10
150
150
Revaluation reserve
11
11,207
11,207
Profit and loss reserves
183,211
183,716
Total equity
194,568
195,073
EUROPEAN HEALTHCARE SOLUTIONS LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 MARCH 2025
31 March 2025
- 2 -
For the financial year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true
The financial statements were approved by the board of directors and authorised for issue on 10 December 2025 and are signed on its behalf by:
Mr N.A.P. Kent
Director
Company registration number 04381321 (England and Wales)
EUROPEAN HEALTHCARE SOLUTIONS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
- 3 -
1
Accounting policies
Company information
European Healthcare Solutions Limited is a private company limited by shares incorporated in England and Wales. The registered office is Lakeview House, 4 Woodbrook Crescent, Billericay, Essex, United Kingdom, CM12 0EQ.
1.1
Basis of preparation
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.
1.2
Turnover
Turnover represents fair value of net invoiced sales of goods, services and commissions earned, excluding value added tax.
1.3
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Plant and machinary
5% on straight line
Fixtures and fittings
30% on reducing balance
Computers equipment
30% on reducing balance
Motor vehicles
18% on reducing balance
1.4
Investment property
Investment property, which is property held to earn rentals and/or for capital appreciation, is initially recognised at cost, which includes the purchase cost and any directly attributable expenditure. Subsequently it is measured at fair value at the reporting end date. Changes in fair value are recognised in profit or loss.
Property rented to a group entity is accounted for at fair value with changes in fair value recognised in profit or loss or as tangible fixed assets.
1.5
Fixed asset investments
Investments in subsidiary undertakings are recognised at cost.
EUROPEAN HEALTHCARE SOLUTIONS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 4 -
1.6
Financial instruments
Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.
Loans and borrowings are initially recognised at the transaction price including transaction costs. Subsequently, they are measured at amortised cost using the effective interest rate method, less impairment. If an arrangement constitutes finance transaction it is measured at present value.
1.7
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
2
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2025
2024
Number
Number
Total
3
3
EUROPEAN HEALTHCARE SOLUTIONS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 5 -
3
Tangible fixed assets
Plant and machinary
Fixtures and fittings
Computers equipment
Motor vehicles
Total
£
£
£
£
£
Cost
At 1 April 2024
25,975
4,068
16,877
70,761
117,681
Additions
2,024
2,024
At 31 March 2025
25,975
4,068
18,901
70,761
119,705
Depreciation and impairment
At 1 April 2024
15,189
1,564
14,058
23,181
53,992
Depreciation charged in the year
1,299
751
1,279
8,564
11,893
At 31 March 2025
16,488
2,315
15,337
31,745
65,885
Carrying amount
At 31 March 2025
9,487
1,753
3,564
39,016
53,820
At 31 March 2024
10,786
2,504
2,819
47,580
63,689
4
Investment property
2025
£
Fair value
At 1 April 2024 and 31 March 2025
215,863
5
Fixed asset investments
2025
2024
£
£
Shares in group undertakings and participating interests
100
100
6
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
3,900
Other debtors
1,948
4,962
1,948
8,862
EUROPEAN HEALTHCARE SOLUTIONS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 6 -
7
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans
6,226
6,226
Trade creditors
2,038
2,064
Taxation and social security
4,164
21,896
Other creditors
52,120
50,799
64,548
80,985
8
Creditors: amounts falling due after more than one year
2025
2024
£
£
Bank loans and overdrafts
19,893
25,513
9
Loans and overdrafts
2025
2024
£
£
Bank loans
26,119
31,739
Payable within one year
6,226
6,226
Payable after one year
19,893
25,513
10
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of 50p each
200
200
100
100
Ordinary A shares of 50p each
100
100
50
50
300
300
150
150
11
Revaluation reserve
2025
2024
£
£
At the beginning and end of the year
11,207
11,207